SCHEMBL2449658

SCHEMBL2449658

Cc1cc(C)c(-c2cccc(O[PH](=O)O)c2-c2c(C)cc(C)cc2C)c(C)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ELANE P08246 3/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
KDM4E B2RXH2 1/20 0.32
USP2 O75604 1/20 0.32
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
BRCA1 P38398 1/20 0.32
RECQL P46063 1/20 0.32
MYC P01106 1/20 0.32
CRHR1 P34998 2/20 0.32
ABCB1 P08183 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
LMNA P02545 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2449657 0.88 MEN1 (0.34) MEN1KMT2AELANEALDH1A1MAPT
SCHEMBL28811047 0.88 PDK2 (0.37) PDK2MEN1KMT2AELANEALDH1A1
SCHEMBL8468313 0.76 PDK2 (0.35) PDK2MEN1KMT2AELANEALDH1A1
SCHEMBL1884447 0.75 PDK2 (0.37) PDK2MEN1KMT2AELANEALDH1A1
SCHEMBL1884446 0.74 CRHR1 (0.36) PDK2MEN1KMT2AALDH1A1MAPT
SCHEMBL8468310 0.74 CRHR1 (0.34) PDK2ALDH1A1MAPTKDM4ETSHR
SCHEMBL2817475 0.70 TP53 (0.40) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL545054 0.70 MAPT (0.47) MEN1KMT2AALDH1A1MAPTTDP1
SCHEMBL4451596 0.69 TSHR (0.41) MEN1KMT2AMAPTTDP1KDM4E
SCHEMBL28592213 0.69 ABCB1 (0.41) MEN1KMT2AELANEMAPTCRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461236-B2 Phosphoric compound, method for preparing the same, and flame retardant thermoplastic resin composition including the same CHEIL INDUSTRIES INC. (KR) 2013-06-11 US claimed
US-20110263768-A1 Phosphoric Compound, Method for Preparing the Same, and Flame Retardant Thermoplastic Resin Composition Including the Same CHEIL INDUSTRIES INC. (KR) 2011-10-27 US claimed
US-8461236-B2 Phosphoric compound, method for preparing the same, and flame retardant thermoplastic resin composition including the same CHEIL INDUSTRIES INC. (KR) 2013-06-11 US disclosed
US-20110263768-A1 Phosphoric Compound, Method for Preparing the Same, and Flame Retardant Thermoplastic Resin Composition Including the Same CHEIL INDUSTRIES INC. (KR) 2011-10-27 US disclosed
EP-2364986-A1 NOVEL PHOSPHATE COMPOUNDS, PREPARATION METHOD THEREOF, AND FLAME-RETARDANT THERMOPLASTIC RESIN COMPOSITIONS USING SAME Cheil Industries Inc. (KR) 2011-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263768-A1 Phosphoric Compound, Method for Preparing the Same, and Flame Retardant Thermoplastic Resin Composition Including the Same PFAS, PPA1, ATIC PDK2 2171/4885MEN1 2678/4885KMT2A 932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.